We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug & Device Products
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Publications
    • Webinar Training Pass
    • eCFR and Guidances
    • Books
  • Clinical Products
  • Advertising
  • White Papers
  • Contact Us
  • About Us
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Store » Webinar Recordings » What CDER Can and Can’t Do: An Inside Look from an Agency Official - Webinar Recording/Transcript

Other Options

Audio Recording/Transcript - Aug. 23, 2018

$287.00

Audio Recording/Transcript - Aug. 23, 2018

$258.00

Audio Recording/Transcript - Aug. 23, 2018

$244.00

Audio Recording/Transcript - Aug. 23, 2018

$230.00

Audio Recording/Transcript - Aug. 23, 2018

$215.00

What CDER Can and Can’t Do: An Inside Look from an Agency Official - Webinar Recording/Transcript

$287.00
Webinar Recordings

Product Details

What CDER Can and Can’t Do: An Inside Look from an Agency Official

CDER, the FDA’s drug-approval arm, pays attention to patient and caregiver input … and so should you.

Starting in the ‘90s and strengthened by the 2012 FDASIA law, CDER has been making concerted efforts to take patient views into account. FDAnews has asked an insider, Dr. Sadhna Khatri, to show you how that process works … and how it affects your new-product approvals.

Dr. Khatri shows you what CDER has done, what it wishes to do, and what law and regulation prevent it from doing. Over a fast-paced hour and a half, she’ll examine:

  • The patient voice: What CDER does to help patients get heard on drug approval, safety and efficacy issues
  • Speedier review: What CDER can do to speed approvals
  • What CDER can’t do: Limitations placed by law and regulation
  • FDASIA: How the 2012 law expands and strengthens agency ability to safeguard public health …
  • Real-world examples: Engagement strategies that work for others
  • How to deal with CDER: Face-to-face, electronically and via postal mail
  • How to request a meeting with CDER
  • And MUCH more!

Patients experience diseases and therapies differently. Each has his/her own perspective on treatments and diagnostic procedures. For successful new-drug applications, it’s essential to understand the patient perspective. An agency outreach specialist shows you what to focus on.

  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell My Personal Information
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Fax 703.538.7676 – Toll free 888.838.5578

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing